ONK Therapeutics
PrivateLast Round
Series A
Jan 6, 2022
Total Funding Raised
$33.45M
Company Overview
ONK Therapeutics operates in Healthcare & Life Sciences and is based in Ireland. Its latest recorded funding round was a Series A round in January 2022.
ONK Therapeutics is a biotechnology company that develops next-generation, off-the-shelf, optimally engineered natural killer (NK) cell therapies for the treatment of hematological malignancies and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ONK Therapeutics Comparables
Compare ONK Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytoImmune Therapeutics | 89% | |
| NK:IO | 84% | |
| Glycostem Therapeutics | 83% |
For institutional investors. Book with your work email.
ONK Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 6, 2022 | ||||
| Grant | Jun 8, 2021 | ||||
| VC Round | Oct 19, 2020 | ||||
| Seed | May 1, 2020 | ||||
| Grant | Dec 10, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ONK Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cormorant Asset Management | Series A |
| Acorn Bioventures | Series A, VC Round |
| Enterprise Ireland | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 39% MoM.
- Nov 9, 2025
Monthly visitors increased 46% MoM.
For institutional investors. Book with your work email.
ONK Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ONK Therapeutics's valuation, stock price, and market status.
Is ONK Therapeutics a public or private company?
ONK Therapeutics is a private company.
What is the current stock price of ONK Therapeutics?
ONK Therapeutics is a private company, so its shares have no public market price. Caplight tracks ONK Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ONK Therapeutics worth (valuation)?
Valuation information for ONK Therapeutics is not publicly available.
Can I buy ONK Therapeutics stock?
ONK Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ONK Therapeutics's last funding round?
ONK Therapeutics's most recent funding round was Series A on January 6, 2022.
Who are the main investors in ONK Therapeutics?
Key investors in ONK Therapeutics include Acorn Bioventures.
Will ONK Therapeutics IPO soon?
No public IPO plans have been announced for ONK Therapeutics.
How can I track ONK Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ONK Therapeutics's shares on secondary markets.